Mineralys Therapeutics Inc.
MLYS | NASDAQ
$28.31
+$0.29 (+1.03%)
At close: Sep 21, 2026, 4:00 PM ET
$28.01
-$0.30 (-1.06%)
Pre-market:
Sep 22, 2026, 4:10 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -349.58M | -151.78M | -154.65M | -171.36M | -190.77M | -188.51M | -177.81M | -153.25M | -119.67M | -90.8M | -71.9M | -56.58M | -40.5M | -34.84M | -29.8M | -27.81M | -21.13M | -14.65M | -7.08M |
Depreciation & Amortization | 154K | 50K | 59K | 61K | 57K | 50K | 43K | 28K | 17K | 8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 25.03M | 22.23M | 19.32M | 17.17M | 14.47M | 9.92M | 8.47M | 6.79M | 5.23M | 6.5M | 5.06M | 3.82M | 2.44M | 1.19M | 455K | 253K | 61K | 35K | 16K |
Other Working Capital | -4.32M | 6.49M | 4.5M | -8.75M | -7.64M | -7.81M | 9.22M | 25.04M | 23.46M | 5.44M | -7.3M | -4.24M | -8.89M | -1.56M | -1.39M | 1.7M | 2.24M | 2.29M | 2.18M |
Other Non-Cash Items | 187.75M | -13.46M | -9.88M | -7.01M | -7.32M | -5.07M | -6.54M | -7.26M | -6.51M | -8.52M | -6.87M | -5.21M | -3.22M | -202K | 1.52M | 1.93M | 1.9M | 864K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.14M | 6.56M | 2.73M | -10.23M | -9.12M | -9.05M | 9.52M | 25.25M | 23.64M | 5.27M | -7.47M | -4.41M | -9.05M | -1.56M | -1.39M | 1.7M | 2.24M | 2.29M | 2.18M |
Operating Cash Flow | -138.79M | -136.4M | -142.42M | -171.37M | -192.69M | -192.66M | -166.31M | -128.45M | -97.3M | -87.54M | -81.17M | -62.38M | -50.34M | -35.42M | -29.22M | -23.93M | -16.94M | -11.47M | -4.89M |
Capital Expenditures | -15K | -15K | -15K | n/a | -37K | -37K | -96K | -96K | -59K | -59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.23B | -1.03B | -814.74M | -610.19M | -368.55M | -377.93M | -373.45M | -382.6M | -379.74M | -308.61M | -347.97M | -274.88M | -290.65M | -234.51M | -71.76M | -71.76M | n/a | n/a | n/a |
Sales Maturities Of Investments | 942.5M | 692.5M | 425M | 407.5M | 396M | 456M | 488.5M | 406M | 327.5M | 232.5M | 187.5M | 122.5M | 62.5M | 22.5M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -200M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50M | 50M | 50M | 50M | n/a | n/a | n/a | n/a |
Investing Cash Flow | -484.16M | -341.82M | -389.75M | -202.69M | 27.42M | 78.04M | 114.96M | 23.3M | -52.3M | -76.17M | -160.47M | -102.38M | -178.15M | -162.01M | -21.76M | -71.76M | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 292K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 249.86M | 6.6M | 6.71M | 6.66M | 25K | -67K | -94K | -47K | -6K | 86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 659.43M | 425.99M | 591M | 494.39M | 199.2M | 189.22M | 116.14M | 116.13M | 116.31M | 115.88M | 203.25M | 202.11M | 201.36M | 319.59M | 128.02M | 129.09M | 129.65M | 12M | n/a |
Net Cash Flow | 36.48M | -52.23M | 58.83M | 120.32M | 33.93M | 74.59M | 64.79M | 10.97M | -33.28M | -47.83M | -38.4M | 37.35M | -27.12M | 122.17M | 77.04M | 33.4M | 112.71M | 529K | -4.89M |
Free Cash Flow | -138.8M | -136.42M | -142.43M | -171.37M | -192.72M | -192.7M | -166.41M | -128.55M | -97.36M | -87.6M | -81.17M | -62.38M | -50.34M | -35.42M | -29.22M | -23.93M | -16.94M | -11.47M | -4.89M |
Adj. Free Cash Flow | -163.83M | -158.64M | -161.76M | -188.54M | -207.19M | -202.62M | -174.88M | -135.34M | -102.58M | -94.1M | -86.23M | -66.2M | -52.77M | -36.6M | -29.68M | -24.18M | -17M | -11.5M | -4.91M |
Maintenance CapEx | -13K | -13K | -13K | n/a | -11K | -11K | -19K | -19K | -8K | -8K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -2K | -2K | -2K | n/a | -26K | -26K | -77K | -77K | -51K | -51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -138.8M | -136.41M | -142.43M | -171.37M | -192.7M | -192.67M | -166.33M | -128.47M | -97.31M | -87.55M | -81.17M | -62.38M | -50.34M | -35.42M | -29.22M | -23.93M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MLYS